ARCHIVES

Wyden Asks Bristol For documentation To Prove That Taxol Price Is Not “Gouging” Taxpayers

This article is from The Cancer Letter archive.

Vol. 19 No. 05 | January 29, 1993

Download PDF Visit The Full Archive

Related Articles

Interim NSABP Leaders Will Not Nominate Chairman, Citing Exec. Committee “Bias”

September 9, 1994

Group Chairmen Accept Most Changes In Terms Of Award, Object To CTEP Adjustments

December 2, 1988

FDA Advisors Recommend Approval Of Topotecan for Ovarian Cancer

April 26, 1996

In Brief: Cancer Program “Strengthened” NIH, Report From Biomedical Research Panel Contends

April 16, 1976

ONF Seeks Applications For Grants In Fatigue

March 31, 1995

Grant Review: NIH Names Members To New Clinical Oncology Review Panel

February 26, 1999